Gene Symbol |
Definition |
Felxi PID |
Halo PID |
Nluc-N PID |
Nluc-C PID |
FASN |
fatty acid synthase |
FXC00314
|
FHC00314
|
FNC00314N
|
FNC00314C
|
RNMT |
RNA (guanine-7-) methyltransferase, transcript variant 2 |
FXC00528
|
FHC00528
|
FNC00528N
|
FNC00528C
|
ACKR4 |
atypical chemokine receptor 4, transcript variant 2 |
FXC00538
|
FHC00538
|
FNC00538N
|
FNC00538C
|
CNOT6 |
CCR4-NOT transcription complex, subunit 6 |
FXC00760
|
FHC00760
|
FNC00760N
|
FNC00760C
|
CCR1 |
chemokine (C-C motif) receptor 1 |
FXC00983
|
FHC00983
|
FNC00983N
|
FNC00983C
|
HGF |
hepatocyte growth factor (hepapoietin A; scatter factor), transcript variant 5 |
FXC01260
|
FHC01260
|
FNC01260N
|
FNC01260C
|
CSF2RB |
colony stimulating factor 2 receptor, beta, low-affinity (granulocyte-macrophage) |
FXC01280
|
FHC01280
|
FNC01280N
|
FNC01280C
|
TGFBR1 |
transforming growth factor, beta receptor 1, transcript variant 1 |
FXC01305
|
FHC01305
|
FNC01305N
|
FNC01305C
|
BMPR2 |
bone morphogenetic protein receptor, type II (serine/threonine kinase) |
FXC01318
|
FHC01318
|
FNC01318N
|
FNC01318C
|
TGFBR2 |
transforming growth factor, beta receptor II (70/80kDa), transcript variant 2 |
FXC01401
|
FHC01401
|
FNC01401N
|
FNC01401C
|
ACVR1B |
activin A receptor, type IB, transcript variant 1 |
FXC01408
|
FHC01408
|
FNC01408N
|
FNC01408C
|
IL6ST |
interleukin 6 signal transducer, transcript variant 1 |
FXC01535
|
FHC01535
|
FNC01535N
|
FNC01535C
|
TNFRSF10B |
tumor necrosis factor receptor superfamily, member 10b, transcript variant 1 |
FXC01547
|
FHC01547
|
FNC01547N
|
FNC01547C
|
PDGFRB |
platelet-derived growth factor receptor, beta polypeptide |
FXC01574
|
FHC01574
|
FNC01574N
|
FNC01574C
|
CXCL12 |
chemokine (C-X-C motif) ligand 12
|
FXC01580
|
FHC01580
|
|
|
ACKR3 |
atypical chemokine receptor 3 |
FXC01768
|
FHC01768
|
FNC01768N
|
FNC01768C
|
KIT |
v-kit Hardy-Zuckerman 4 feline sarcoma viral oncogene homolog, transcript variant 2 |
FXC01839
|
FHC01839
|
FNC01839N
|
FNC01839C
|
FLT1 |
fms-related tyrosine kinase 1, transcript variant 1 |
FXC01847
|
FHC01847
|
FNC01847N
|
FNC01847C
|
IL2RB |
interleukin 2 receptor, beta |
FXC02076
|
FHC02076
|
FNC02076N
|
FNC02076C
|
KITLG |
KIT ligand, transcript variant b |
FXC02130
|
FHC02130
|
FNC02130N
|
FNC02130C
|
EDA |
ectodysplasin A, transcript variant 2 |
FXC02133
|
FHC02133
|
FNC02133N
|
FNC02133C
|
IL3RA |
interleukin 3 receptor, alpha (low affinity), transcript variant 1 |
FXC02171
|
FHC02171
|
FNC02171N
|
FNC02171C
|
INHBA |
inhibin, beta A |
FXC02222
|
FHC02222
|
FNC02222N
|
FNC02222C
|
IFNA16 |
interferon, alpha 16 |
FXC02322
|
FHC02322
|
FNC02322N
|
FNC02322C
|
IFNK |
interferon, kappa |
FXC02335
|
FHC02335
|
FNC02335N
|
FNC02335C
|
BMP2 |
bone morphogenetic protein 2 |
FXC02340
|
FHC02340
|
FNC02340N
|
FNC02340C
|
MPL |
MPL proto-oncogene, thrombopoietin receptor |
FXC02342
|
FHC02342
|
FNC02342N
|
FNC02342C
|
PDGFA |
platelet-derived growth factor alpha polypeptide, transcript variant 2 |
FXC02363
|
FHC02363
|
FNC02363N
|
FNC02363C
|
SOS1 |
son of sevenless homolog 1 (Drosophila) |
FXC02380
|
FHC02380
|
FNC02380N
|
FNC02380C
|
IL19 |
interleukin 19, transcript variant 1 |
FXC02467
|
FHC02467
|
FNC02467N
|
FNC02467C
|
TNF |
tumor necrosis factor |
FXC02535
|
FHC02535
|
FNC02535N
|
FNC02535C
|
PRLR |
prolactin receptor, transcript variant 1 |
FXC02789
|
FHC02789
|
FNC02789N
|
FNC02789C
|
OSM |
oncostatin M |
FXC02855
|
FHC02855
|
FNC02855N
|
FNC02855C
|
XCR1 |
chemokine (C motif) receptor 1, transcript variant 1 |
FXC03028
|
FHC03028
|
FNC03028N
|
FNC03028C
|
CXCR6 |
chemokine (C-X-C motif) receptor 6 |
FXC03032
|
FHC03032
|
FNC03032N
|
FNC03032C
|
CCR3 |
chemokine (C-C motif) receptor 3, transcript variant 1 |
FXC03035
|
FHC03035
|
FNC03035N
|
FNC03035C
|
CCR8 |
chemokine (C-C motif) receptor 8 |
FXC03036
|
FHC03036
|
FNC03036N
|
FNC03036C
|
CCR4 |
chemokine (C-C motif) receptor 4 |
FXC03037
|
FHC03037
|
FNC03037N
|
FNC03037C
|
ACKR2 |
atypical chemokine receptor 2 |
FXC03044
|
FHC03044
|
FNC03044N
|
FNC03044C
|
CXCR3 |
chemokine (C-X-C motif) receptor 3, transcript variant 2 |
FXC03047
|
FHC03047
|
FNC03047N
|
FNC03047C
|
LEP |
leptin |
FXC03079
|
FHC03079
|
FNC03079N
|
FNC03079C
|
CCR9 |
chemokine (C-C motif) receptor 9, transcript variant A |
FXC03123
|
FHC03123
|
FNC03123N
|
FNC03123C
|
CXCR5 |
chemokine (C-X-C motif) receptor 5, transcript variant 1 |
FXC03124
|
FHC03124
|
FNC03124N
|
FNC03124C
|
CCR2 |
chemokine (C-C motif) receptor 2, transcript variant A |
FXC03125
|
FHC03125
|
FNC03125N
|
FNC03125C
|
IFNA1 |
interferon, alpha 1 |
FXC03299
|
FHC03299
|
FNC03299N
|
FNC03299C
|
IFNW1 |
interferon, omega 1 |
FXC03302
|
FHC03302
|
FNC03302N
|
FNC03302C
|
CXCR1 |
chemokine (C-X-C motif) receptor 1 |
FXC03346
|
FHC03346
|
FNC03346N
|
FNC03346C
|
CCR5 |
chemokine (C-C motif) receptor 5 (gene/pseudogene), transcript variant A |
FXC03348
|
FHC03348
|
FNC03348N
|
FNC03348C
|
CXCR2 |
chemokine (C-X-C motif) receptor 2, transcript variant 1 |
FXC03352
|
FHC03352
|
FNC03352N
|
FNC03352C
|
BMPR1B |
bone morphogenetic protein receptor, type IB, transcript variant 2 |
FXC03435
|
FHC03435
|
FNC03435N
|
FNC03435C
|
LTBR |
lymphotoxin beta receptor (TNFR superfamily, member 3), transcript variant 1 |
FXC03475
|
FHC03475
|
FNC03475N
|
FNC03475C
|
IL23A |
interleukin 23, alpha subunit p19 |
FXC03630
|
FHC03630
|
FNC03630N
|
FNC03630C
|
LIF |
leukemia inhibitory factor, transcript variant 1 |
FXC03637
|
FHC03637
|
FNC03637N
|
FNC03637C
|
CSF1 |
colony stimulating factor 1 (macrophage), transcript variant 1 |
FXC03695
|
FHC03695
|
FNC03695N
|
FNC03695C
|
EPOR |
erythropoietin receptor, transcript variant 1 |
FXC03734
|
FHC03734
|
FNC03734N
|
FNC03734C
|
IL6R |
interleukin 6 receptor, transcript variant 1 |
FXC03794
|
FHC03794
|
FNC03794N
|
FNC03794C
|
EDAR |
ectodysplasin A receptor |
FXC03799
|
FHC03799
|
FNC03799N
|
FNC03799C
|
CCL14 |
chemokine (C-C motif) ligand 14, transcript variant 3 |
FXC03823
|
FHC03823
|
FNC03823N
|
FNC03823C
|
CCL16 |
chemokine (C-C motif) ligand 16 |
FXC03856
|
FHC03856
|
FNC03856N
|
FNC03856C
|
IFNGR1 |
interferon gamma receptor 1 |
FXC03908
|
FHC03908
|
FNC03908N
|
FNC03908C
|
PF4 |
platelet factor 4 |
FXC03919
|
FHC03919
|
FNC03919N
|
FNC03919C
|
EDA2R |
ectodysplasin A2 receptor, transcript variant 2 |
FXC03935
|
FHC03935
|
FNC03935N
|
FNC03935C
|
IFNAR2 |
interferon (alpha, beta and omega) receptor 2, transcript variant 1 |
FXC03967
|
FHC03967
|
FNC03967N
|
FNC03967C
|
ACVR1 |
activin A receptor, type I, transcript variant 1 |
FXC03971
|
FHC03971
|
FNC03971N
|
FNC03971C
|
TNFRSF13C |
tumor necrosis factor receptor superfamily, member 13C |
FXC03995
|
FHC03995
|
FNC03995N
|
FNC03995C
|
CCL11 |
chemokine (C-C motif) ligand 11 |
FXC04470
|
FHC04470
|
FNC04470N
|
FNC04470C
|
CCL13 |
chemokine (C-C motif) ligand 13 |
FXC04471
|
FHC04471
|
FNC04471N
|
FNC04471C
|
CCL15 |
chemokine (C-C motif) ligand 15 |
FXC04472
|
FHC04472
|
FNC04472N
|
FNC04472C
|
CCL2 |
chemokine (C-C motif) ligand 2 |
FXC04473
|
FHC04473
|
FNC04473N
|
FNC04473C
|
CCL21 |
chemokine (C-C motif) ligand 21 |
FXC04474
|
FHC04474
|
FNC04474N
|
FNC04474C
|
CCL3 |
chemokine (C-C motif) ligand 3 |
FXC04475
|
FHC04475
|
FNC04475N
|
FNC04475C
|
CCL4L1 |
chemokine (C-C motif) ligand 4-like 1, transcript variant CCL4L |
FXC04476
|
FHC04476
|
FNC04476N
|
FNC04476C
|
CCL5 |
chemokine (C-C motif) ligand 5, transcript variant 1 |
FXC04477
|
FHC04477
|
FNC04477N
|
FNC04477C
|
CXCL14 |
chemokine (C-X-C motif) ligand 14 |
FXC04686
|
FHC04686
|
FNC04686N
|
FNC04686C
|
CXCL16 |
chemokine (C-X-C motif) ligand 16, transcript variant 1 |
FXC04687
|
FHC04687
|
FNC04687N
|
FNC04687C
|
CXCL6 |
chemokine (C-X-C motif) ligand 6 |
FXC04688
|
FHC04688
|
FNC04688N
|
FNC04688C
|
EPO |
erythropoietin |
FXC04906
|
FHC04906
|
FNC04906N
|
FNC04906C
|
EPX |
eosinophil peroxidase |
FXC04907
|
FHC04907
|
FNC04907N
|
FNC04907C
|
FAS |
Fas cell surface death receptor |
FXC04988
|
FHC04988
|
FNC04988N
|
FNC04988C
|
IFNGR2 |
interferon gamma receptor 2 (interferon gamma transducer 1) |
FXC05491
|
FHC05491
|
FNC05491N
|
FNC05491C
|
IL13 |
interleukin 13 |
FXC05505
|
FHC05505
|
FNC05505N
|
FNC05505C
|
IL17RA |
interleukin 17 receptor A, transcript variant 1 |
FXC05508
|
FHC05508
|
FNC05508N
|
FNC05508C
|
IL1A |
interleukin 1, alpha |
FXC05509
|
FHC05509
|
FNC05509N
|
FNC05509C
|
IL1B |
interleukin 1, beta |
FXC05510
|
FHC05510
|
FNC05510N
|
FNC05510C
|
IFNLR1 |
interferon, lambda receptor 1, transcript variant 1 |
FXC05512
|
FHC05512
|
FNC05512N
|
FNC05512C
|
IL2RG |
interleukin 2 receptor, gamma |
FXC05514
|
FHC05514
|
FNC05514N
|
FNC05514C
|
INHBB |
inhibin, beta B |
FXC05519
|
FHC05519
|
FNC05519N
|
FNC05519C
|
CCR10 |
chemokine (C-C motif) receptor 10 |
FXC05684
|
FHC05684
|
FNC05684N
|
FNC05684C
|
LIFR |
leukemia inhibitory factor receptor alpha, transcript variant 2 |
FXC05827
|
FHC05827
|
FNC05827N
|
FNC05827C
|
PDGFB |
platelet-derived growth factor beta polypeptide, transcript variant 1 |
FXC06311
|
FHC06311
|
FNC06311N
|
FNC06311C
|
PPBP |
pro-platelet basic protein (chemokine (C-X-C motif) ligand 7) |
FXC06444
|
FHC06444
|
FNC06444N
|
FNC06444C
|
IL10 |
interleukin 10 |
FXC07552
|
FHC07552
|
FNC07552N
|
FNC07552C
|
IFNE |
interferon, epsilon |
FXC07643
|
FHC07643
|
FNC07643N
|
FNC07643C
|
CXCL12 |
chemokine (C-X-C motif) ligand 12, transcript variant 3 |
FXC07713
|
FHC07713
|
FNC07713N
|
FNC07713C
|
CX3CR1 |
chemokine (C-X3-C motif) receptor 1, transcript variant 1 |
FXC07732
|
FHC07732
|
FNC07732N
|
FNC07732C
|
TIMP1 |
TIMP metallopeptidase inhibitor 1 |
FXC07922
|
FHC07922
|
FNC07922N
|
FNC07922C
|
IL17RB |
interleukin 17 receptor B |
FXC07935
|
FHC07935
|
FNC07935N
|
FNC07935C
|
IL10RB |
interleukin 10 receptor, beta |
FXC08036
|
FHC08036
|
FNC08036N
|
FNC08036C
|
CSF2RA |
colony stimulating factor 2 receptor, alpha, low-affinity (granulocyte-macrophage), transcript variant 1 |
FXC08089
|
FHC08089
|
FNC08089N
|
FNC08089C
|
TNFRSF12A |
tumor necrosis factor receptor superfamily, member 12A |
FXC08102
|
FHC08102
|
FNC08102N
|
FNC08102C
|
IL21R |
interleukin 21 receptor, transcript variant 1 |
FXC08180
|
FHC08180
|
FNC08180N
|
FNC08180C
|
CXCL11 |
chemokine (C-X-C motif) ligand 11, transcript variant 1 |
FXC08240
|
FHC08240
|
FNC08240N
|
FNC08240C
|
TNFRSF9 |
tumor necrosis factor receptor superfamily, member 9 |
FXC08266
|
FHC08266
|
FNC08266N
|
FNC08266C
|
CXCL5 |
chemokine (C-X-C motif) ligand 5 |
FXC08368
|
FHC08368
|
FNC08368N
|
FNC08368C
|
BMP7 |
bone morphogenetic protein 7 |
FXC08377
|
FHC08377
|
FNC08377N
|
FNC08377C
|
IL13RA1 |
interleukin 13 receptor, alpha 1 |
FXC08469
|
FHC08469
|
FNC08469N
|
FNC08469C
|
TNFRSF1A |
tumor necrosis factor receptor superfamily, member 1A |
FXC08484
|
FHC08484
|
FNC08484N
|
FNC08484C
|
CXCL1 |
chemokine (C-X-C motif) ligand 1 (melanoma growth stimulating activity, alpha), transcript variant 1 |
FXC08597
|
FHC08597
|
FNC08597N
|
FNC08597C
|
CD27 |
CD27 molecule |
FXC08615
|
FHC08615
|
FNC08615N
|
FNC08615C
|
CD40 |
CD40 molecule, TNF receptor superfamily member 5, transcript variant 1 |
FXC08629
|
FHC08629
|
FNC08629N
|
FNC08629C
|
TNFRSF10A |
tumor necrosis factor receptor superfamily, member 10a |
FXC08654
|
FHC08654
|
FNC08654N
|
FNC08654C
|
CLCF1 |
cardiotrophin-like cytokine factor 1, transcript variant 1 |
FXC08663
|
FHC08663
|
FNC08663N
|
FNC08663C
|
CXCL8 |
chemokine (C-X-C motif) ligand 8 |
FXC08702
|
FHC08702
|
FNC08702N
|
FNC08702C
|
IL6 |
interleukin 6 |
FXC08788
|
FHC08788
|
FNC08788N
|
FNC08788C
|
PRL |
prolactin, transcript variant 1 |
FXC08822
|
FHC08822
|
FNC08822N
|
FNC08822C
|
CX3CL1 |
chemokine (C-X3-C motif) ligand 1, transcript variant 1 |
FXC08831
|
FHC08831
|
FNC08831N
|
FNC08831C
|
FASLG |
Fas ligand (TNF superfamily, member 6), transcript variant 1 |
FXC08901
|
FHC08901
|
FNC08901N
|
FNC08901C
|
TNFRSF21 |
tumor necrosis factor receptor superfamily, member 21 |
FXC08912
|
FHC08912
|
FNC08912N
|
FNC08912C
|
TNFSF13B |
tumor necrosis factor (ligand) superfamily, member 13b, transcript variant 1 |
FXC09023
|
FHC09023
|
FNC09023N
|
FNC09023C
|
CCL22 |
chemokine (C-C motif) ligand 22 |
FXC09225
|
FHC09225
|
FNC09225N
|
FNC09225C
|
IL10RA |
interleukin 10 receptor, alpha, transcript variant 1 |
FXC09242
|
FHC09242
|
FNC09242N
|
FNC09242C
|
BMPR1A |
bone morphogenetic protein receptor, type IA |
FXC09257
|
FHC09257
|
FNC09257N
|
FNC09257C
|
TNFRSF11B |
tumor necrosis factor receptor superfamily, member 11b |
FXC09319
|
FHC09319
|
FNC09319N
|
FNC09319C
|
TNFSF10 |
tumor necrosis factor (ligand) superfamily, member 10, transcript variant 1 |
FXC09450
|
FHC09450
|
FNC09450N
|
FNC09450C
|
VEGFC |
vascular endothelial growth factor C |
FXC09559
|
FHC09559
|
FNC09559N
|
FNC09559C
|
CCR7 |
C-C motif chemokine receptor, transcript variant 1 |
FXC09567
|
FHC09567
|
FNC09567N
|
FNC09567C
|
EGFR |
epidermal growth factor receptor, transcript variant 1 |
FXC09683
|
FHC09683
|
FNC09683N
|
FNC09683C
|
CNTFR |
ciliary neurotrophic factor receptor, transcript variant 2 |
FXC09768
|
FHC09768
|
FNC09768N
|
FNC09768C
|
VEGFB |
vascular endothelial growth factor B, transcript variant VEGFB-186 |
FXC09942
|
FHC09942
|
FNC09942N
|
FNC09942C
|
IL24 |
interleukin 24, transcript variant 3 |
FXC09955
|
FHC09955
|
FNC09955N
|
FNC09955C
|
CXCL3 |
chemokine (C-X-C motif) ligand 3 |
FXC10068
|
FHC10068
|
FNC10068N
|
FNC10068C
|
IL15 |
interleukin 15, transcript variant 3 |
FXC10094
|
FHC10094
|
FNC10094N
|
FNC10094C
|
CCL19 |
chemokine (C-C motif) ligand 19 |
FXC10218
|
FHC10218
|
FNC10218N
|
FNC10218C
|
LTA |
lymphotoxin alpha, transcript variant 2 |
FXC10320
|
FHC10320
|
FNC10320N
|
FNC10320C
|
CCR6 |
chemokine (C-C motif) receptor 6, transcript variant 1 |
FXC10350
|
FHC10350
|
FNC10350N
|
FNC10350C
|
CCL20 |
chemokine (C-C motif) ligand 20, transcript variant 2 |
FXC10373
|
FHC10373
|
FNC10373N
|
FNC10373C
|
CSF1R |
colony stimulating factor 1 receptor, transcript variant 1 |
FXC10479
|
FHC10479
|
FNC10479N
|
FNC10479C
|
CCL7 |
chemokine (C-C motif) ligand 7 |
FXC10485
|
FHC10485
|
FNC10485N
|
FNC10485C
|
IFNB1 |
interferon, beta 1, fibroblast |
FXC10486
|
FHC10486
|
FNC10486N
|
FNC10486C
|
IL7 |
interleukin 7, transcript variant 2 |
FXC10487
|
FHC10487
|
FNC10487N
|
FNC10487C
|
IL12A |
interleukin 12A |
FXC10673
|
FHC10673
|
FNC10673N
|
FNC10673C
|
IFNAR1 |
interferon (alpha, beta and omega) receptor 1 |
FXC10692
|
FHC10692
|
FNC10692N
|
FNC10692C
|
TNFRSF11A |
tumor necrosis factor receptor superfamily, member 11a, NFKB activator, transcript variant 1 |
FXC10751
|
FHC10751
|
FNC10751N
|
FNC10751C
|
PDGFB |
platelet-derived growth factor beta polypeptide |
FXC10772
|
FHC10772
|
FNC10772N
|
FNC10772C
|
TNFSF4 |
tumor necrosis factor (ligand) superfamily, member 4, transcript variant 1 |
FXC10802
|
FHC10802
|
FNC10802N
|
FNC10802C
|
ENC1 |
ectodermal-neural cortex 1 (with BTB domain), transcript variant 1 |
FXC10803
|
FHC10803
|
FNC10803N
|
FNC10803C
|
IL15RA |
interleukin 15 receptor, alpha |
FXC10822
|
FHC10822
|
FNC10822N
|
FNC10822C
|
CCL28 |
chemokine (C-C motif) ligand 28, transcript variant 1 |
FXC10862
|
FHC10862
|
FNC10862N
|
FNC10862C
|
CCL1 |
chemokine (C-C motif) ligand 1 |
FXC10873
|
FHC10873
|
FNC10873N
|
FNC10873C
|
TNFSF14 |
tumor necrosis factor (ligand) superfamily, member 14, transcript variant 1 |
FXC10892
|
FHC10892
|
FNC10892N
|
FNC10892C
|
TGFB2 |
transforming growth factor, beta 2, transcript variant 1 |
FXC10973
|
FHC10973
|
FNC10973N
|
FNC10973C
|
CCL8 |
chemokine (C-C motif) ligand 8 |
FXC10976
|
FHC10976
|
FNC10976N
|
FNC10976C
|
IL2RA |
interleukin 2 receptor, alpha, transcript variant 1 |
FXC11183
|
FHC11183
|
FNC11183N
|
FNC11183C
|
CXCR4 |
chemokine (C-X-C motif) receptor 4, transcript variant 1 |
FXC11275
|
FHC11275
|
FNC11275N
|
FNC11275C
|
TNFRSF17 |
tumor necrosis factor receptor superfamily, member 17 |
FXC11365
|
FHC11365
|
FNC11365N
|
FNC11365C
|
ACVR2A |
activin A receptor, type IIA, transcript variant 2 |
FXC11423
|
FHC11423
|
FNC11423N
|
FNC11423C
|
OSMR |
oncostatin M receptor, transcript variant 1 |
FXC11634
|
FHC11634
|
FNC11634N
|
FNC11634C
|
CXCL10 |
chemokine (C-X-C motif) ligand 10 |
FXC11687
|
FHC11687
|
FNC11687N
|
FNC11687C
|
ACVR2B |
activin A receptor, type IIB |
FXC11748
|
FHC11748
|
FNC11748N
|
FNC11748C
|
CCL27 |
chemokine (C-C motif) ligand 27 |
FXC11762
|
FHC11762
|
FNC11762N
|
FNC11762C
|
CCL25 |
chemokine (C-C motif) ligand 25, transcript variant 2 |
FXC11763
|
FHC11763
|
FNC11763N
|
FNC11763C
|
TNFRSF14 |
tumor necrosis factor receptor superfamily, member 14, transcript variant 1 |
FXC11863
|
FHC11863
|
FNC11863N
|
FNC11863C
|
IL9R |
interleukin 9 receptor |
FXC12238
|
FHC12238
|
FNC12238N
|
FNC12238C
|
IL1R1 |
interleukin 1 receptor, type I, transcript variant 1 |
FXC12556
|
FHC12556
|
FNC12556N
|
FNC12556C
|
IL12RB1 |
interleukin 12 receptor, beta 1, transcript variant 1 |
FXC12558
|
FHC12558
|
FNC12558N
|
FNC12558C
|
PDGFRA |
platelet derived growth factor receptor alpha |
FXC12575
|
FHC12575
|
FNC12575N
|
FNC12575C
|
CCL4 |
chemokine (C-C motif) ligand 4 |
FXC12584
|
FHC12584
|
FNC12584N
|
FNC12584C
|
CRLF2 |
cytokine receptor-like factor 2, transcript variant 1 |
FXC12624
|
FHC12624
|
FNC12624N
|
FNC12624C
|
MET |
MET proto-oncogene, receptor tyrosine kinase, transcript variant 2 |
FXC12649
|
FHC12649
|
FNC12649N
|
FNC12649C
|
CNTF |
ciliary neurotrophic factor |
FXC12716
|
FHC12716
|
FNC12716N
|
FNC12716C
|
VEGFA |
vascular endothelial growth factor A, transcript variant 6 |
FXC13139
|
FHC13139
|
FNC13139N
|
FNC13139C
|
CCM2 |
cerebral cavernous malformation 2 |
FXC13153
|
FHC13153
|
FNC13153N
|
FNC13153C
|
TNFSF18 |
tumor necrosis factor (ligand) superfamily, member 18 |
FXC14055
|
FHC14055
|
FNC14055N
|
FNC14055C
|
IFNA13 |
interferon, alpha 13 |
FXC15894
|
FHC15894
|
FNC15894N
|
FNC15894C
|
TNFRSF4 |
tumor necrosis factor receptor superfamily, member 4 |
FXC20008
|
FHC20008
|
FNC20008N
|
FNC20008C
|
TNFRSF25 |
tumor necrosis factor receptor superfamily, member 25, transcript variant 2 |
FXC20050
|
FHC20050
|
FNC20050N
|
FNC20050C
|
TNFRSF1B |
tumor necrosis factor receptor superfamily, member 1B |
FXC20088
|
FHC20088
|
FNC20088N
|
FNC20088C
|
IL22RA1 |
interleukin 22 receptor, alpha 1 |
FXC20138
|
FHC20138
|
FNC20138N
|
FNC20138C
|
LEPR |
leptin receptor, transcript variant 1
|
FXC20344
|
FHC20344
|
|
|
IL23R |
interleukin 23 receptor |
FXC20351
|
FHC20351
|
FNC20351N
|
FNC20351C
|
XCL2 |
chemokine (C motif) ligand 2 |
FXC20701
|
FHC20701
|
FNC20701N
|
FNC20701C
|
IL20 |
interleukin 20 |
FXC20796
|
FHC20796
|
FNC20796N
|
FNC20796C
|
IL1R2 |
interleukin 1 receptor, type II, transcript variant 1 |
FXC21118
|
FHC21118
|
FNC21118N
|
FNC21118C
|
IL18R1 |
interleukin 18 receptor 1, transcript variant 1 |
FXC21121
|
FHC21121
|
FNC21121N
|
FNC21121C
|
IL18RAP |
interleukin 18 receptor accessory protein |
FXC21122
|
FHC21122
|
FNC21122N
|
FNC21122C
|
IL5RA |
interleukin 5 receptor, alpha, transcript variant 1 |
FXC21407
|
FHC21407
|
FNC21407N
|
FNC21407C
|
IL20RB |
interleukin 20 receptor beta |
FXC21704
|
FHC21704
|
FNC21704N
|
FNC21704C
|
THPO |
thrombopoietin, transcript variant 1 |
FXC21783
|
FHC21783
|
FNC21783N
|
FNC21783C
|
IL1RAP |
interleukin 1 receptor accessory protein, transcript variant 1 |
FXC21810
|
FHC21810
|
FNC21810N
|
FNC21810C
|
KDR |
kinase insert domain receptor (a type III receptor tyrosine kinase) |
FXC21921
|
FHC21921
|
FNC21921N
|
FNC21921C
|
PF4V1 |
platelet factor 4 variant 1 |
FXC21959
|
FHC21959
|
FNC21959N
|
FNC21959C
|
CXCL13 |
chemokine (C-X-C motif) ligand 13 |
FXC21964
|
FHC21964
|
FNC21964N
|
FNC21964C
|
IL21 |
interleukin 21, transcript variant 1 |
FXC22046
|
FHC22046
|
FNC22046N
|
FNC22046C
|
PDGFC |
platelet derived growth factor C, transcript variant 1 |
FXC22085
|
FHC22085
|
FNC22085N
|
FNC22085C
|
TSLP |
thymic stromal lymphopoietin, transcript variant 1 |
FXC22243
|
FHC22243
|
FNC22243N
|
FNC22243C
|
IL9 |
interleukin 9 |
FXC22288
|
FHC22288
|
FNC22288N
|
FNC22288C
|
IL17B |
interleukin 17B |
FXC22349
|
FHC22349
|
FNC22349N
|
FNC22349C
|
IL12B |
interleukin 12B |
FXC22371
|
FHC22371
|
FNC22371N
|
FNC22371C
|
VEGFA |
vascular endothelial growth factor A
|
FXC22633
|
FHC22633
|
|
|
IL17A |
interleukin 17A |
FXC22655
|
FHC22655
|
FNC22655N
|
FNC22655C
|
CCL26 |
chemokine (C-C motif) ligand 26 |
FXC22957
|
FHC22957
|
FNC22957N
|
FNC22957C
|
TNFRSF10C |
tumor necrosis factor receptor superfamily, member 10c, decoy without an intracellular domain |
FXC23212
|
FHC23212
|
FNC23212N
|
FNC23212C
|
TNFRSF10D |
tumor necrosis factor receptor superfamily, member 10d, decoy with truncated death domain |
FXC23213
|
FHC23213
|
FNC23213N
|
FNC23213C
|
IFNA21 |
interferon, alpha 21 |
FXC23475
|
FHC23475
|
FNC23475N
|
FNC23475C
|
IFNA4 |
interferon, alpha 4 |
FXC23476
|
FHC23476
|
FNC23476N
|
FNC23476C
|
IFNA10 |
interferon, alpha 10 |
FXC23477
|
FHC23477
|
FNC23477N
|
FNC23477C
|
IFNA17 |
interferon, alpha 17 |
FXC23478
|
FHC23478
|
FNC23478N
|
FNC23478C
|
IFNA14 |
interferon, alpha 14 |
FXC23479
|
FHC23479
|
FNC23479N
|
FNC23479C
|
IFNA5 |
interferon, alpha 5 |
FXC23480
|
FHC23480
|
FNC23480N
|
FNC23480C
|
IFNA6 |
interferon, alpha 6 |
FXC23481
|
FHC23481
|
FNC23481N
|
FNC23481C
|
IFNA2 |
interferon, alpha 2 |
FXC23482
|
FHC23482
|
FNC23482N
|
FNC23482C
|
IFNA8 |
interferon, alpha 8 |
FXC23483
|
FHC23483
|
FNC23483N
|
FNC23483C
|
TNFSF15 |
tumor necrosis factor (ligand) superfamily, member 15, transcript variant 1 |
FXC23616
|
FHC23616
|
FNC23616N
|
FNC23616C
|
TNFSF8 |
tumor necrosis factor (ligand) superfamily, member 8, transcript variant 1 |
FXC23617
|
FHC23617
|
FNC23617N
|
FNC23617C
|
AMHR2 |
anti-Mullerian hormone receptor, type II, transcript variant 1 |
FXC24752
|
FHC24752
|
FNC24752N
|
FNC24752C
|
INHBC |
inhibin, beta C |
FXC24781
|
FHC24781
|
FNC24781N
|
FNC24781C
|
INHBE |
inhibin, beta E |
FXC24782
|
FHC24782
|
FNC24782N
|
FNC24782C
|
IFNG |
interferon, gamma |
FXC24802
|
FHC24802
|
FNC24802N
|
FNC24802C
|
IL26 |
interleukin 26 |
FXC24803
|
FHC24803
|
FNC24803N
|
FNC24803C
|
IL22 |
interleukin 22 |
FXC24804
|
FHC24804
|
FNC24804N
|
FNC24804C
|
TNFSF11 |
tumor necrosis factor superfamily member, transcript variant 1 |
FXC24993
|
FHC24993
|
FNC24993N
|
FNC24993C
|
IL25 |
interleukin 25, transcript variant 1 |
FXC25103
|
FHC25103
|
FNC25103N
|
FNC25103C
|
TGFB3 |
transforming growth factor, beta 3 |
FXC25244
|
FHC25244
|
FNC25244N
|
FNC25244C
|
IL4R |
interleukin 4 receptor, transcript variant 1 |
FXC25645
|
FHC25645
|
FNC25645N
|
FNC25645C
|
CCL17 |
chemokine (C-C motif) ligand 17 |
FXC25709
|
FHC25709
|
FNC25709N
|
FNC25709C
|
TNFSF12 |
tumor necrosis factor (ligand) superfamily, member 12, transcript variant 1 |
FXC25874
|
FHC25874
|
FNC25874N
|
FNC25874C
|
CCL23 |
chemokine (C-C motif) ligand 23, transcript variant CKbeta8 |
FXC25971
|
FHC25971
|
FNC25971N
|
FNC25971C
|
CCL18 |
chemokine (C-C motif) ligand 18 (pulmonary and activation-regulated) |
FXC25972
|
FHC25972
|
FNC25972N
|
FNC25972C
|
NGFR |
nerve growth factor receptor
|
FXC26099
|
FHC26099
|
|
|
AMH |
anti-Mullerian hormone |
FXC26382
|
FHC26382
|
FNC26382N
|
FNC26382C
|
MYDGF |
myeloid-derived growth factor |
FXC26407
|
FHC26407
|
FNC26407N
|
FNC26407C
|
TNFSF9 |
tumor necrosis factor (ligand) superfamily, member 9 |
FXC26426
|
FHC26426
|
FNC26426N
|
FNC26426C
|
CD70 |
CD70 molecule |
FXC26427
|
FHC26427
|
FNC26427N
|
FNC26427C
|
IFNL3 |
interferon, lambda 3 |
FXC26621
|
FHC26621
|
FNC26621N
|
FNC26621C
|
IFNL1 |
interferon, lambda 1 |
FXC26622
|
FHC26622
|
FNC26622N
|
FNC26622C
|
FLT3LG |
fms-related tyrosine kinase 3 ligand, transcript variant 3 |
FXC26740
|
FHC26740
|
FNC26740N
|
FNC26740C
|
IL11 |
interleukin 11, transcript variant 1 |
FXC26823
|
FHC26823
|
FNC26823N
|
FNC26823C
|
GDF5 |
growth differentiation factor 5 |
FXC26979
|
FHC26979
|
FNC26979N
|
FNC26979C
|
TNFRSF6B |
tumor necrosis factor receptor superfamily, member 6b, decoy |
FXC27108
|
FHC27108
|
FNC27108N
|
FNC27108C
|
FIGF |
c-fos induced growth factor (vascular endothelial growth factor D) |
FXC27307
|
FHC27307
|
FNC27307N
|
FNC27307C
|
CD40LG |
CD40 ligand |
FXC27535
|
FHC27535
|
FNC27535N
|
FNC27535C
|
FLT3 |
fms-related tyrosine kinase 3, transcript variant 1 |
FXC28201
|
FHC28201
|
FNC28201N
|
FNC28201C
|
CCL3L3 |
chemokine (C-C motif) ligand 3-like 3 |
FXC28460
|
FHC28460
|
FNC28460N
|
FNC28460C
|
TGFB1 |
transforming growth factor, beta 1 |
FXC28628
|
FHC28628
|
FNC28628N
|
FNC28628C
|
CXCL2 |
chemokine (C-X-C motif) ligand 2 |
FXC28990
|
FHC28990
|
FNC28990N
|
FNC28990C
|
CXCL9 |
chemokine (C-X-C motif) ligand 9 |
FXC28992
|
FHC28992
|
FNC28992N
|
FNC28992C
|
CCL24 |
chemokine (C-C motif) ligand 24 |
FXC29239
|
FHC29239
|
FNC29239N
|
FNC29239C
|
IFNA7 |
interferon, alpha 7 |
FXC29362
|
FHC29362
|
FNC29362N
|
FNC29362C
|
IFNL2 |
interferon, lambda 2 |
FXC29927
|
FHC29927
|
FNC29927N
|
FNC29927C
|
IL18 |
interleukin 18, transcript variant 1 |
FXC30506
|
FHC30506
|
FNC30506N
|
FNC30506C
|
XCL1 |
chemokine (C motif) ligand 1 |
FXC31349
|
FHC31349
|
FNC31349N
|
FNC31349C
|
IL2 |
interleukin 2 |
FXC31382
|
FHC31382
|
FNC31382N
|
FNC31382C
|
IL3 |
interleukin 3 |
FXC31395
|
FHC31395
|
FNC31395N
|
FNC31395C
|
CSF2 |
colony stimulating factor 2 (granulocyte-macrophage) |
FXC31396
|
FHC31396
|
FNC31396N
|
FNC31396C
|
IL5 |
interleukin 5 |
FXC31397
|
FHC31397
|
FNC31397N
|
FNC31397C
|
IL4 |
interleukin 4, transcript variant 1 |
FXC31398
|
FHC31398
|
FNC31398N
|
FNC31398C
|
LTB |
lymphotoxin beta (TNF superfamily, member 3), transcript variant 1 |
FXC31407
|
FHC31407
|
FNC31407N
|
FNC31407C
|
TNFSF13 |
tumor necrosis factor (ligand) superfamily, member 13, transcript variant alpha |
FXC31548
|
FHC31548
|
FNC31548N
|
FNC31548C
|
CSF3 |
colony stimulating factor 3 (granulocyte), transcript variant 2 |
FXC31555
|
FHC31555
|
FNC31555N
|
FNC31555C
|
GH2 |
growth hormone 2, transcript variant 1 |
FXC31562
|
FHC31562
|
FNC31562N
|
FNC31562C
|
GH1 |
growth hormone 1, transcript variant 1 |
FXC31566
|
FHC31566
|
FNC31566N
|
FNC31566C
|
IL20RA |
interleukin 20 receptor, alpha, transcript variant 1 |
FXC31740
|
FHC31740
|
FNC31740N
|
FNC31740C
|